The chitosan and polyvinyl alcohol composite hydrogel containing hTGFβ - 1 gene modified BMSCs was injected into rabbits with defective articular cartilage.
The settlement agreement proposes to resolve 8,000 claims filed by patients who received Johnson & Johnson's defective DePuy Articular Surface Replacement (ASR) Hip System devices.